Menu
Recruiting NCT06970288

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

— Observational Breast Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Breast Carcinoma. Basic parameters: 30 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.

Primary outcome measures

  • To evaluate the capability of detecting suspicious breast lesions using non-contrast enhanced MRI protocol featuring ultra-high B-value [Time frame: 20 months]

Eligibility criteria

Inclusion criteria

  • • Women with suspicious breast mass (BIRADS 4a)
  • High risk women (Positive family history)
  • Women with suspicious axillary lymph nodes by Ultrasound
  • Women with dense breasts coming for MRI imaging.

Exclusion criteria

  • • Contraindications to MRI
  • Pacemaker, cochlear implant, claustrophobia, ocular implants
  • Contraindications to contrast administration:
  • Elevated kidney functions
  • Women who haven't undergone reliable Mammogram \& Ultrasound
  • Women with prior treatment or intervention (e.g. biopsy)
  • Patients' refusal.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Egypt · 1 center
  • Ain Shams University — Cairo

Identifiers

NCT: NCT06970288 · MD45/2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗